Related Experiment Video

Updated: Jul 8, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

Zihan Qu1, Jiajun Dong2, Zhong-Yin Zhang1,2,3,4

  • 1Department of Chemistry, Purdue University, West Lafayette, Indiana, USA.

British Journal of Pharmacology
|December 20, 2023
PubMed

Insights

New cancer immunotherapy strategies focus on protein tyrosine phosphatases (PTPs) to overcome treatment limitations. Targeting PTPs offers a novel approach to enhance immune response and antigen presentation for improved cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Current cancer immunotherapies face challenges including limited patient response, drug resistance, and adverse effects.
  • Protein tyrosine phosphatases (PTPs) are key regulators of cellular processes with potential for immune modulation.
  • Targeting PTPs presents a novel strategy to improve cancer immunotherapy outcomes.

Purpose of the Study:

  • To review recent advances in targeting PTPs for cancer immunotherapy.
  • To highlight the genetic and biological validation of PTPs as therapeutic targets.
  • To discuss the development of small molecule inhibitors and degraders for PTP-targeted cancer therapy.

Main Methods:

  • Literature review of genetic and biological validation studies for PTP targets.
  • Analysis of recent developments in small molecule inhibitors and degraders targeting PTPs.
  • Synthesis of current research on PTPs in cancer immunotherapy.

Main Results:

  • Several PTPs have been genetically and biologically validated as promising targets for cancer immunotherapy.
  • Small molecule inhibitors and degraders targeting specific PTPs are emerging as novel therapeutic agents.
  • Targeting PTPs demonstrates potential to modulate immune responses and antigen presentation.

Conclusions:

  • PTPs represent a significant new class of targets for developing next-generation cancer immunotherapies.
  • Targeting PTPs offers a promising avenue to overcome existing limitations in cancer treatment.
  • Further research into PTP-targeted therapies could lead to more effective and safer cancer treatments.
Keywords:
cancer immunotherapyprotein tyrosine phosphatasesmall molecule inhibitortarget validation

More Related Videos

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

395
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370